Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$611K Buy
4,519
+409
+10% +$53.6K ﹤0.01% 887
2019
Q2
$502K Buy
4,110
+376
+10% +$41.6K ﹤0.01% 969
2019
Q1
$388K Sell
3,734
-767
-17% -$79.2K ﹤0.01% 1009
2018
Q4
$512K Sell
4,501
-157
-3% -$16.8K ﹤0.01% 881
2018
Q3
$537K Sell
4,658
-133
-3% -$14.6K ﹤0.01% 896
2018
Q2
$496K Buy
4,791
+1,888
+65% +$191K ﹤0.01% 922
2018
Q1
$286K Buy
+2,903
New +$274K ﹤0.01% 1077
2014
Q4
Sell
-5,139
Closed -$252K 1282
2014
Q3
$252K Sell
5,139
-3,246
-39% -$165K ﹤0.01% 1241
2014
Q2
$422K Sell
8,385
-14,741
-64% -$731K ﹤0.01% 1068
2014
Q1
$1.03M Buy
23,126
+1,414
+7% +$63.5K ﹤0.01% 940
2013
Q4
$1.02M Buy
21,712
+1,423
+7% +$72K ﹤0.01% 914
2013
Q3
$1.07M Buy
20,289
+1,322
+7% +$64.1K ﹤0.01% 861
2013
Q2
$855K Buy
+18,967
New +$900K ﹤0.01% 909

Other funds holding RMD

Suntrust Banks's RMD Position: Q3 2019 in Review

Suntrust Banks increased its ResMed (RMD) stake by 10% in Q3 2019, buying an estimated $53.6K and bringing the position to 4,519 shares worth $611K. The position accounts for ﹤0.01% of the portfolio, ranked #887.

Suntrust Banks first reported a position in RMD in Q2 2013 and has held it in 13 quarters since. The position peaked at $1.07M in Q3 2013. 528 funds tracked by Wall St. Rank hold RMD as of Q3 2019.

  • Suntrust Banks held 4,519 shares of ResMed worth $611K as of Q3 2019.
  • Suntrust Banks bought 409 ResMed shares in Q3 2019, an estimated $53.6K.
  • ResMed made up ﹤0.01% of Suntrust Banks's portfolio in Q3 2019, its #887 holding.
  • Suntrust Banks first reported a position in ResMed in Q2 2013 and has held it in 13 quarters since.
  • Suntrust Banks's ResMed position peaked at $1.07M in Q3 2013.
  • 528 funds tracked by Wall St. Rank held ResMed as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.